source
- Novartis projects slowed growth, pins hopes on billions in pipeline potentialWith Kisqali going off patent and decreasing prices impacting sales, Novartis has narrowed sales guidance to 5% growth. But management remains steadfast that they have a plan to get back on track.BioSpace · 41m ago↗ source
- Why Oura is buying CounselEvery year at HLTH, there is usually one piece of news that everyone has an opinion about. This year, it was Oura buying Counsel Health. That’s for good reason. It’s been rare to see a ...Endpoints · 42m ago↗ source
- STAT+: Epic defends competitive practices; promises AI access to recordsIn this edition of STAT Health Tech: EHR giant, Epic defends its competitive tactics, new data on AI and health care costs, and HLTH news.STAT · 2h ago